nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—MAOA—alcohol dependence	0.344	0.512	CbGaD
Naratriptan—HTR1B—alcohol dependence	0.328	0.488	CbGaD
Naratriptan—MAOA—locus ceruleus—alcohol dependence	0.00638	0.162	CbGeAlD
Naratriptan—HTR1F—forebrain—alcohol dependence	0.00261	0.0663	CbGeAlD
Naratriptan—MAOA—nerve—alcohol dependence	0.00191	0.0484	CbGeAlD
Naratriptan—HTR1F—nervous system—alcohol dependence	0.00142	0.036	CbGeAlD
Naratriptan—HTR1F—central nervous system—alcohol dependence	0.00137	0.0347	CbGeAlD
Naratriptan—HTR1B—brainstem—alcohol dependence	0.00111	0.0282	CbGeAlD
Naratriptan—HTR1F—brain—alcohol dependence	0.00109	0.0275	CbGeAlD
Naratriptan—HTR1D—brainstem—alcohol dependence	0.00107	0.0273	CbGeAlD
Naratriptan—HTR1B—forebrain—alcohol dependence	0.00107	0.0272	CbGeAlD
Naratriptan—HTR1D—forebrain—alcohol dependence	0.00104	0.0263	CbGeAlD
Naratriptan—HTR1B—cardiovascular system—alcohol dependence	0.000906	0.023	CbGeAlD
Naratriptan—HTR1A—brainstem—alcohol dependence	0.000896	0.0227	CbGeAlD
Naratriptan—HTR1D—cardiovascular system—alcohol dependence	0.000877	0.0223	CbGeAlD
Naratriptan—Almotriptan—MAOA—alcohol dependence	0.000875	0.152	CrCbGaD
Naratriptan—HTR1A—forebrain—alcohol dependence	0.000865	0.0219	CbGeAlD
Naratriptan—Sumatriptan—MAOA—alcohol dependence	0.000842	0.146	CrCbGaD
Naratriptan—Almotriptan—HTR1B—alcohol dependence	0.000835	0.145	CrCbGaD
Naratriptan—MAOA—brainstem—alcohol dependence	0.000818	0.0208	CbGeAlD
Naratriptan—Sumatriptan—HTR1B—alcohol dependence	0.000804	0.14	CrCbGaD
Naratriptan—MAOA—forebrain—alcohol dependence	0.00079	0.02	CbGeAlD
Naratriptan—MAOA—adrenal cortex—alcohol dependence	0.000732	0.0186	CbGeAlD
Naratriptan—HTR1A—cardiovascular system—alcohol dependence	0.000731	0.0185	CbGeAlD
Naratriptan—HTR1B—midbrain—alcohol dependence	0.000707	0.0179	CbGeAlD
Naratriptan—HTR1D—midbrain—alcohol dependence	0.000685	0.0174	CbGeAlD
Naratriptan—Eletriptan—HTR7—alcohol dependence	0.000672	0.117	CrCbGaD
Naratriptan—MAOA—cardiovascular system—alcohol dependence	0.000668	0.0169	CbGeAlD
Naratriptan—Eletriptan—HTR1B—alcohol dependence	0.00065	0.113	CrCbGaD
Naratriptan—MAOA—pancreas—alcohol dependence	0.000649	0.0165	CbGeAlD
Naratriptan—HTR1B—endocrine gland—alcohol dependence	0.000621	0.0158	CbGeAlD
Naratriptan—HTR1B—nervous system—alcohol dependence	0.000582	0.0148	CbGeAlD
Naratriptan—HTR1A—midbrain—alcohol dependence	0.000571	0.0145	CbGeAlD
Naratriptan—HTR1D—nervous system—alcohol dependence	0.000563	0.0143	CbGeAlD
Naratriptan—HTR1B—central nervous system—alcohol dependence	0.00056	0.0142	CbGeAlD
Naratriptan—MAOA—digestive system—alcohol dependence	0.000554	0.0141	CbGeAlD
Naratriptan—HTR1D—central nervous system—alcohol dependence	0.000542	0.0138	CbGeAlD
Naratriptan—Sumatriptan—DRD2—alcohol dependence	0.00054	0.0938	CrCbGaD
Naratriptan—Almotriptan—CYP2E1—alcohol dependence	0.00054	0.0938	CrCbGaD
Naratriptan—MAOA—blood—alcohol dependence	0.000528	0.0134	CbGeAlD
Naratriptan—MAOA—midbrain—alcohol dependence	0.000522	0.0132	CbGeAlD
Naratriptan—Liver function test abnormal—Acamprosate—alcohol dependence	0.000519	0.00326	CcSEcCtD
Naratriptan—Musculoskeletal stiffness—Citalopram—alcohol dependence	0.000517	0.00325	CcSEcCtD
Naratriptan—Dry skin—Acamprosate—alcohol dependence	0.000515	0.00323	CcSEcCtD
Naratriptan—Paraesthesia—Disulfiram—alcohol dependence	0.000503	0.00316	CcSEcCtD
Naratriptan—HTR1A—endocrine gland—alcohol dependence	0.000501	0.0127	CbGeAlD
Naratriptan—Somnolence—Disulfiram—alcohol dependence	0.000498	0.00313	CcSEcCtD
Naratriptan—Gastritis—Acamprosate—alcohol dependence	0.000497	0.00312	CcSEcCtD
Naratriptan—Dehydration—Naltrexone—alcohol dependence	0.000494	0.00311	CcSEcCtD
Naratriptan—Hypercholesterolaemia—Citalopram—alcohol dependence	0.00049	0.00308	CcSEcCtD
Naratriptan—Asthma—Acamprosate—alcohol dependence	0.000485	0.00305	CcSEcCtD
Naratriptan—Bone pain—Citalopram—alcohol dependence	0.000484	0.00304	CcSEcCtD
Naratriptan—Fatigue—Disulfiram—alcohol dependence	0.000483	0.00304	CcSEcCtD
Naratriptan—Pain—Disulfiram—alcohol dependence	0.000479	0.00301	CcSEcCtD
Naratriptan—Cramp muscle—Naltrexone—alcohol dependence	0.000479	0.00301	CcSEcCtD
Naratriptan—Angina pectoris—Acamprosate—alcohol dependence	0.000473	0.00297	CcSEcCtD
Naratriptan—Muscle twitching—Citalopram—alcohol dependence	0.000472	0.00297	CcSEcCtD
Naratriptan—Coordination abnormal—Citalopram—alcohol dependence	0.000472	0.00297	CcSEcCtD
Naratriptan—HTR1A—nervous system—alcohol dependence	0.000469	0.0119	CbGeAlD
Naratriptan—Bronchitis—Acamprosate—alcohol dependence	0.000467	0.00293	CcSEcCtD
Naratriptan—Ventricular tachycardia—Citalopram—alcohol dependence	0.000464	0.00291	CcSEcCtD
Naratriptan—Blood pressure increased—Citalopram—alcohol dependence	0.000464	0.00291	CcSEcCtD
Naratriptan—Vaginal inflammation—Citalopram—alcohol dependence	0.000464	0.00291	CcSEcCtD
Naratriptan—MAOA—endocrine gland—alcohol dependence	0.000458	0.0116	CbGeAlD
Naratriptan—Cystitis noninfective—Citalopram—alcohol dependence	0.000453	0.00285	CcSEcCtD
Naratriptan—HTR1A—central nervous system—alcohol dependence	0.000452	0.0115	CbGeAlD
Naratriptan—Pollakiuria—Acamprosate—alcohol dependence	0.000448	0.00282	CcSEcCtD
Naratriptan—Urinary incontinence—Citalopram—alcohol dependence	0.000448	0.00281	CcSEcCtD
Naratriptan—Cystitis—Citalopram—alcohol dependence	0.000448	0.00281	CcSEcCtD
Naratriptan—Depressed level of consciousness—Citalopram—alcohol dependence	0.000448	0.00281	CcSEcCtD
Naratriptan—Angina pectoris—Naltrexone—alcohol dependence	0.000447	0.00281	CcSEcCtD
Naratriptan—HTR1B—brain—alcohol dependence	0.000445	0.0113	CbGeAlD
Naratriptan—Photosensitivity reaction—Acamprosate—alcohol dependence	0.000443	0.00278	CcSEcCtD
Naratriptan—Bronchitis—Naltrexone—alcohol dependence	0.000442	0.00278	CcSEcCtD
Naratriptan—HTR1A—cerebellum—alcohol dependence	0.000442	0.0112	CbGeAlD
Naratriptan—Fluid retention—Citalopram—alcohol dependence	0.00044	0.00277	CcSEcCtD
Naratriptan—Abdominal discomfort—Naltrexone—alcohol dependence	0.00044	0.00277	CcSEcCtD
Naratriptan—Vaginal infection—Citalopram—alcohol dependence	0.000438	0.00275	CcSEcCtD
Naratriptan—Hyperglycaemia—Acamprosate—alcohol dependence	0.000438	0.00275	CcSEcCtD
Naratriptan—MAOA—testis—alcohol dependence	0.000437	0.0111	CbGeAlD
Naratriptan—Photophobia—Citalopram—alcohol dependence	0.000435	0.00274	CcSEcCtD
Naratriptan—Pneumonia—Acamprosate—alcohol dependence	0.000435	0.00274	CcSEcCtD
Naratriptan—Depression—Acamprosate—alcohol dependence	0.000432	0.00271	CcSEcCtD
Naratriptan—HTR1D—brain—alcohol dependence	0.00043	0.0109	CbGeAlD
Naratriptan—MAOA—nervous system—alcohol dependence	0.000429	0.0109	CbGeAlD
Naratriptan—Dry eye—Citalopram—alcohol dependence	0.000428	0.00269	CcSEcCtD
Naratriptan—Acute coronary syndrome—Acamprosate—alcohol dependence	0.000427	0.00268	CcSEcCtD
Naratriptan—Myocardial infarction—Acamprosate—alcohol dependence	0.000424	0.00267	CcSEcCtD
Naratriptan—Oesophagitis—Citalopram—alcohol dependence	0.000424	0.00266	CcSEcCtD
Naratriptan—Urine output increased—Citalopram—alcohol dependence	0.000419	0.00263	CcSEcCtD
Naratriptan—Bladder pain—Citalopram—alcohol dependence	0.000419	0.00263	CcSEcCtD
Naratriptan—Sweating—Acamprosate—alcohol dependence	0.000415	0.00261	CcSEcCtD
Naratriptan—MAOA—liver—alcohol dependence	0.000413	0.0105	CbGeAlD
Naratriptan—MAOA—central nervous system—alcohol dependence	0.000413	0.0105	CbGeAlD
Naratriptan—Pneumonia—Naltrexone—alcohol dependence	0.000412	0.00259	CcSEcCtD
Naratriptan—Depression—Naltrexone—alcohol dependence	0.000408	0.00257	CcSEcCtD
Naratriptan—Hyperkinesia—Citalopram—alcohol dependence	0.000405	0.00254	CcSEcCtD
Naratriptan—Acute coronary syndrome—Naltrexone—alcohol dependence	0.000404	0.00254	CcSEcCtD
Naratriptan—MAOA—cerebellum—alcohol dependence	0.000403	0.0102	CbGeAlD
Naratriptan—Asthenia—Disulfiram—alcohol dependence	0.000402	0.00253	CcSEcCtD
Naratriptan—Myocardial infarction—Naltrexone—alcohol dependence	0.000401	0.00252	CcSEcCtD
Naratriptan—Haemoglobin—Acamprosate—alcohol dependence	0.000391	0.00245	CcSEcCtD
Naratriptan—Sleep disorder—Citalopram—alcohol dependence	0.000389	0.00244	CcSEcCtD
Naratriptan—Haemorrhage—Acamprosate—alcohol dependence	0.000389	0.00244	CcSEcCtD
Naratriptan—Hallucination—Acamprosate—alcohol dependence	0.000387	0.00243	CcSEcCtD
Naratriptan—Hypoaesthesia—Acamprosate—alcohol dependence	0.000387	0.00243	CcSEcCtD
Naratriptan—Sinusitis—Naltrexone—alcohol dependence	0.000384	0.00241	CcSEcCtD
Naratriptan—Polyuria—Citalopram—alcohol dependence	0.000383	0.00241	CcSEcCtD
Naratriptan—Gastroenteritis—Citalopram—alcohol dependence	0.00038	0.00239	CcSEcCtD
Naratriptan—Vascular purpura—Citalopram—alcohol dependence	0.000376	0.00236	CcSEcCtD
Naratriptan—Eye pain—Citalopram—alcohol dependence	0.000373	0.00234	CcSEcCtD
Naratriptan—Dizziness—Disulfiram—alcohol dependence	0.000371	0.00233	CcSEcCtD
Naratriptan—Hallucination—Naltrexone—alcohol dependence	0.000366	0.0023	CcSEcCtD
Naratriptan—Libido decreased—Citalopram—alcohol dependence	0.000363	0.00228	CcSEcCtD
Naratriptan—Tinnitus—Acamprosate—alcohol dependence	0.000362	0.00228	CcSEcCtD
Naratriptan—HTR1A—brain—alcohol dependence	0.000359	0.0091	CbGeAlD
Naratriptan—Atrial fibrillation—Citalopram—alcohol dependence	0.000355	0.00223	CcSEcCtD
Naratriptan—Thirst—Citalopram—alcohol dependence	0.000354	0.00222	CcSEcCtD
Naratriptan—Rash—Disulfiram—alcohol dependence	0.000353	0.00222	CcSEcCtD
Naratriptan—Headache—Disulfiram—alcohol dependence	0.000351	0.00221	CcSEcCtD
Naratriptan—Immune system disorder—Acamprosate—alcohol dependence	0.000351	0.00221	CcSEcCtD
Naratriptan—Purpura—Citalopram—alcohol dependence	0.000349	0.00219	CcSEcCtD
Naratriptan—Chills—Acamprosate—alcohol dependence	0.000349	0.00219	CcSEcCtD
Naratriptan—Cerebrovascular accident—Citalopram—alcohol dependence	0.000344	0.00216	CcSEcCtD
Naratriptan—Alopecia—Acamprosate—alcohol dependence	0.000343	0.00216	CcSEcCtD
Naratriptan—Tinnitus—Naltrexone—alcohol dependence	0.000343	0.00215	CcSEcCtD
Naratriptan—Cardiac disorder—Naltrexone—alcohol dependence	0.000341	0.00214	CcSEcCtD
Naratriptan—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.000334	0.0021	CcSEcCtD
Naratriptan—Angiopathy—Naltrexone—alcohol dependence	0.000334	0.0021	CcSEcCtD
Naratriptan—Immune system disorder—Naltrexone—alcohol dependence	0.000332	0.00209	CcSEcCtD
Naratriptan—Migraine—Citalopram—alcohol dependence	0.000331	0.00208	CcSEcCtD
Naratriptan—Chills—Naltrexone—alcohol dependence	0.00033	0.00207	CcSEcCtD
Naratriptan—MAOA—brain—alcohol dependence	0.000328	0.00832	CbGeAlD
Naratriptan—Muscle spasms—Acamprosate—alcohol dependence	0.000325	0.00204	CcSEcCtD
Naratriptan—Alopecia—Naltrexone—alcohol dependence	0.000325	0.00204	CcSEcCtD
Naratriptan—Tremor—Acamprosate—alcohol dependence	0.000317	0.00199	CcSEcCtD
Naratriptan—Ill-defined disorder—Acamprosate—alcohol dependence	0.000314	0.00197	CcSEcCtD
Naratriptan—Dehydration—Citalopram—alcohol dependence	0.000313	0.00197	CcSEcCtD
Naratriptan—Anaemia—Acamprosate—alcohol dependence	0.000313	0.00196	CcSEcCtD
Naratriptan—Liver function test abnormal—Citalopram—alcohol dependence	0.000311	0.00195	CcSEcCtD
Naratriptan—Agitation—Acamprosate—alcohol dependence	0.000311	0.00195	CcSEcCtD
Naratriptan—Dry skin—Citalopram—alcohol dependence	0.000309	0.00194	CcSEcCtD
Naratriptan—Muscle spasms—Naltrexone—alcohol dependence	0.000308	0.00193	CcSEcCtD
Naratriptan—Malaise—Acamprosate—alcohol dependence	0.000305	0.00192	CcSEcCtD
Naratriptan—Vertigo—Acamprosate—alcohol dependence	0.000304	0.00191	CcSEcCtD
Naratriptan—Syncope—Acamprosate—alcohol dependence	0.000303	0.00191	CcSEcCtD
Naratriptan—Cramp muscle—Citalopram—alcohol dependence	0.000303	0.00191	CcSEcCtD
Naratriptan—Vision blurred—Naltrexone—alcohol dependence	0.000302	0.0019	CcSEcCtD
Naratriptan—Tremor—Naltrexone—alcohol dependence	0.0003	0.00188	CcSEcCtD
Naratriptan—Palpitations—Acamprosate—alcohol dependence	0.000299	0.00188	CcSEcCtD
Naratriptan—Gastritis—Citalopram—alcohol dependence	0.000298	0.00187	CcSEcCtD
Naratriptan—Loss of consciousness—Acamprosate—alcohol dependence	0.000297	0.00187	CcSEcCtD
Naratriptan—Ill-defined disorder—Naltrexone—alcohol dependence	0.000297	0.00187	CcSEcCtD
Naratriptan—Cough—Acamprosate—alcohol dependence	0.000295	0.00185	CcSEcCtD
Naratriptan—Agitation—Naltrexone—alcohol dependence	0.000294	0.00185	CcSEcCtD
Naratriptan—Convulsion—Acamprosate—alcohol dependence	0.000293	0.00184	CcSEcCtD
Naratriptan—Asthma—Citalopram—alcohol dependence	0.000291	0.00183	CcSEcCtD
Naratriptan—Malaise—Naltrexone—alcohol dependence	0.000289	0.00181	CcSEcCtD
Naratriptan—Myalgia—Acamprosate—alcohol dependence	0.000288	0.00181	CcSEcCtD
Naratriptan—Arthralgia—Acamprosate—alcohol dependence	0.000288	0.00181	CcSEcCtD
Naratriptan—Syncope—Naltrexone—alcohol dependence	0.000287	0.0018	CcSEcCtD
Naratriptan—Anxiety—Acamprosate—alcohol dependence	0.000287	0.0018	CcSEcCtD
Naratriptan—Discomfort—Acamprosate—alcohol dependence	0.000285	0.00179	CcSEcCtD
Naratriptan—Angina pectoris—Citalopram—alcohol dependence	0.000283	0.00178	CcSEcCtD
Naratriptan—Palpitations—Naltrexone—alcohol dependence	0.000283	0.00178	CcSEcCtD
Naratriptan—Dry mouth—Acamprosate—alcohol dependence	0.000282	0.00177	CcSEcCtD
Naratriptan—Loss of consciousness—Naltrexone—alcohol dependence	0.000281	0.00177	CcSEcCtD
Naratriptan—Bronchitis—Citalopram—alcohol dependence	0.00028	0.00176	CcSEcCtD
Naratriptan—Cough—Naltrexone—alcohol dependence	0.000279	0.00175	CcSEcCtD
Naratriptan—Abdominal discomfort—Citalopram—alcohol dependence	0.000279	0.00175	CcSEcCtD
Naratriptan—Confusional state—Acamprosate—alcohol dependence	0.000278	0.00175	CcSEcCtD
Naratriptan—Convulsion—Naltrexone—alcohol dependence	0.000277	0.00174	CcSEcCtD
Naratriptan—Anaphylactic shock—Acamprosate—alcohol dependence	0.000276	0.00173	CcSEcCtD
Naratriptan—Infection—Acamprosate—alcohol dependence	0.000274	0.00172	CcSEcCtD
Naratriptan—Arthralgia—Naltrexone—alcohol dependence	0.000272	0.00171	CcSEcCtD
Naratriptan—Myalgia—Naltrexone—alcohol dependence	0.000272	0.00171	CcSEcCtD
Naratriptan—Shock—Acamprosate—alcohol dependence	0.000272	0.00171	CcSEcCtD
Naratriptan—Anxiety—Naltrexone—alcohol dependence	0.000272	0.00171	CcSEcCtD
Naratriptan—Thrombocytopenia—Acamprosate—alcohol dependence	0.00027	0.0017	CcSEcCtD
Naratriptan—Discomfort—Naltrexone—alcohol dependence	0.000269	0.00169	CcSEcCtD
Naratriptan—Pollakiuria—Citalopram—alcohol dependence	0.000269	0.00169	CcSEcCtD
Naratriptan—Skin disorder—Acamprosate—alcohol dependence	0.000268	0.00168	CcSEcCtD
Naratriptan—Hyperhidrosis—Acamprosate—alcohol dependence	0.000267	0.00168	CcSEcCtD
Naratriptan—Dry mouth—Naltrexone—alcohol dependence	0.000266	0.00167	CcSEcCtD
Naratriptan—Photosensitivity reaction—Citalopram—alcohol dependence	0.000266	0.00167	CcSEcCtD
Naratriptan—Confusional state—Naltrexone—alcohol dependence	0.000263	0.00165	CcSEcCtD
Naratriptan—Hyperglycaemia—Citalopram—alcohol dependence	0.000263	0.00165	CcSEcCtD
Naratriptan—Oedema—Naltrexone—alcohol dependence	0.000261	0.00164	CcSEcCtD
Naratriptan—Anaphylactic shock—Naltrexone—alcohol dependence	0.000261	0.00164	CcSEcCtD
Naratriptan—Pneumonia—Citalopram—alcohol dependence	0.000261	0.00164	CcSEcCtD
Naratriptan—Infection—Naltrexone—alcohol dependence	0.000259	0.00163	CcSEcCtD
Naratriptan—Depression—Citalopram—alcohol dependence	0.000259	0.00163	CcSEcCtD
Naratriptan—Hypotension—Acamprosate—alcohol dependence	0.000258	0.00162	CcSEcCtD
Naratriptan—Shock—Naltrexone—alcohol dependence	0.000257	0.00161	CcSEcCtD
Naratriptan—Nervous system disorder—Naltrexone—alcohol dependence	0.000256	0.00161	CcSEcCtD
Naratriptan—Acute coronary syndrome—Citalopram—alcohol dependence	0.000256	0.00161	CcSEcCtD
Naratriptan—Myocardial infarction—Citalopram—alcohol dependence	0.000254	0.0016	CcSEcCtD
Naratriptan—Neuropathy peripheral—Citalopram—alcohol dependence	0.000254	0.0016	CcSEcCtD
Naratriptan—Skin disorder—Naltrexone—alcohol dependence	0.000254	0.00159	CcSEcCtD
Naratriptan—Hyperhidrosis—Naltrexone—alcohol dependence	0.000252	0.00159	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000252	0.00158	CcSEcCtD
Naratriptan—Sweating—Citalopram—alcohol dependence	0.000249	0.00156	CcSEcCtD
Naratriptan—Paraesthesia—Acamprosate—alcohol dependence	0.000248	0.00156	CcSEcCtD
Naratriptan—Dyspnoea—Acamprosate—alcohol dependence	0.000246	0.00155	CcSEcCtD
Naratriptan—Somnolence—Acamprosate—alcohol dependence	0.000245	0.00154	CcSEcCtD
Naratriptan—Sinusitis—Citalopram—alcohol dependence	0.000243	0.00153	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000238	0.0015	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000238	0.0015	CcSEcCtD
Naratriptan—Bradycardia—Citalopram—alcohol dependence	0.000237	0.00149	CcSEcCtD
Naratriptan—Constipation—Acamprosate—alcohol dependence	0.000236	0.00148	CcSEcCtD
Naratriptan—Pain—Acamprosate—alcohol dependence	0.000236	0.00148	CcSEcCtD
Naratriptan—Paraesthesia—Naltrexone—alcohol dependence	0.000235	0.00147	CcSEcCtD
Naratriptan—Haemoglobin—Citalopram—alcohol dependence	0.000234	0.00147	CcSEcCtD
Naratriptan—Haemorrhage—Citalopram—alcohol dependence	0.000233	0.00146	CcSEcCtD
Naratriptan—Dyspnoea—Naltrexone—alcohol dependence	0.000233	0.00146	CcSEcCtD
Naratriptan—Somnolence—Naltrexone—alcohol dependence	0.000232	0.00146	CcSEcCtD
Naratriptan—Hypoaesthesia—Citalopram—alcohol dependence	0.000232	0.00146	CcSEcCtD
Naratriptan—Hallucination—Citalopram—alcohol dependence	0.000232	0.00146	CcSEcCtD
Naratriptan—Feeling abnormal—Acamprosate—alcohol dependence	0.000227	0.00143	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000225	0.00142	CcSEcCtD
Naratriptan—Fatigue—Naltrexone—alcohol dependence	0.000225	0.00141	CcSEcCtD
Naratriptan—Pain—Naltrexone—alcohol dependence	0.000223	0.0014	CcSEcCtD
Naratriptan—Constipation—Naltrexone—alcohol dependence	0.000223	0.0014	CcSEcCtD
Naratriptan—Urticaria—Acamprosate—alcohol dependence	0.000219	0.00138	CcSEcCtD
Naratriptan—Body temperature increased—Acamprosate—alcohol dependence	0.000218	0.00137	CcSEcCtD
Naratriptan—Tinnitus—Citalopram—alcohol dependence	0.000217	0.00136	CcSEcCtD
Naratriptan—Cardiac disorder—Citalopram—alcohol dependence	0.000216	0.00136	CcSEcCtD
Naratriptan—Feeling abnormal—Naltrexone—alcohol dependence	0.000215	0.00135	CcSEcCtD
Naratriptan—Angiopathy—Citalopram—alcohol dependence	0.000211	0.00133	CcSEcCtD
Naratriptan—Immune system disorder—Citalopram—alcohol dependence	0.00021	0.00132	CcSEcCtD
Naratriptan—Chills—Citalopram—alcohol dependence	0.000209	0.00131	CcSEcCtD
Naratriptan—Arrhythmia—Citalopram—alcohol dependence	0.000208	0.00131	CcSEcCtD
Naratriptan—Urticaria—Naltrexone—alcohol dependence	0.000207	0.0013	CcSEcCtD
Naratriptan—Body temperature increased—Naltrexone—alcohol dependence	0.000206	0.0013	CcSEcCtD
Naratriptan—Alopecia—Citalopram—alcohol dependence	0.000206	0.00129	CcSEcCtD
Naratriptan—Hypersensitivity—Acamprosate—alcohol dependence	0.000203	0.00128	CcSEcCtD
Naratriptan—Erythema—Citalopram—alcohol dependence	0.000203	0.00127	CcSEcCtD
Naratriptan—Asthenia—Acamprosate—alcohol dependence	0.000198	0.00124	CcSEcCtD
Naratriptan—Pruritus—Acamprosate—alcohol dependence	0.000195	0.00123	CcSEcCtD
Naratriptan—Muscle spasms—Citalopram—alcohol dependence	0.000195	0.00122	CcSEcCtD
Naratriptan—Hypersensitivity—Naltrexone—alcohol dependence	0.000192	0.00121	CcSEcCtD
Naratriptan—Vision blurred—Citalopram—alcohol dependence	0.000191	0.0012	CcSEcCtD
Naratriptan—Tremor—Citalopram—alcohol dependence	0.00019	0.00119	CcSEcCtD
Naratriptan—Diarrhoea—Acamprosate—alcohol dependence	0.000189	0.00119	CcSEcCtD
Naratriptan—Ill-defined disorder—Citalopram—alcohol dependence	0.000188	0.00118	CcSEcCtD
Naratriptan—Anaemia—Citalopram—alcohol dependence	0.000187	0.00118	CcSEcCtD
Naratriptan—Asthenia—Naltrexone—alcohol dependence	0.000187	0.00118	CcSEcCtD
Naratriptan—Agitation—Citalopram—alcohol dependence	0.000186	0.00117	CcSEcCtD
Naratriptan—Pruritus—Naltrexone—alcohol dependence	0.000185	0.00116	CcSEcCtD
Naratriptan—Malaise—Citalopram—alcohol dependence	0.000183	0.00115	CcSEcCtD
Naratriptan—Dizziness—Acamprosate—alcohol dependence	0.000183	0.00115	CcSEcCtD
Naratriptan—Vertigo—Citalopram—alcohol dependence	0.000182	0.00114	CcSEcCtD
Naratriptan—Syncope—Citalopram—alcohol dependence	0.000182	0.00114	CcSEcCtD
Naratriptan—Palpitations—Citalopram—alcohol dependence	0.000179	0.00113	CcSEcCtD
Naratriptan—Diarrhoea—Naltrexone—alcohol dependence	0.000179	0.00112	CcSEcCtD
Naratriptan—Loss of consciousness—Citalopram—alcohol dependence	0.000178	0.00112	CcSEcCtD
Naratriptan—Cough—Citalopram—alcohol dependence	0.000177	0.00111	CcSEcCtD
Naratriptan—Convulsion—Citalopram—alcohol dependence	0.000176	0.0011	CcSEcCtD
Naratriptan—Vomiting—Acamprosate—alcohol dependence	0.000176	0.0011	CcSEcCtD
Naratriptan—Rash—Acamprosate—alcohol dependence	0.000174	0.00109	CcSEcCtD
Naratriptan—Dermatitis—Acamprosate—alcohol dependence	0.000174	0.00109	CcSEcCtD
Naratriptan—Headache—Acamprosate—alcohol dependence	0.000173	0.00109	CcSEcCtD
Naratriptan—Dizziness—Naltrexone—alcohol dependence	0.000173	0.00109	CcSEcCtD
Naratriptan—Arthralgia—Citalopram—alcohol dependence	0.000173	0.00108	CcSEcCtD
Naratriptan—Myalgia—Citalopram—alcohol dependence	0.000173	0.00108	CcSEcCtD
Naratriptan—Anxiety—Citalopram—alcohol dependence	0.000172	0.00108	CcSEcCtD
Naratriptan—Discomfort—Citalopram—alcohol dependence	0.000171	0.00107	CcSEcCtD
Naratriptan—Dry mouth—Citalopram—alcohol dependence	0.000169	0.00106	CcSEcCtD
Naratriptan—Confusional state—Citalopram—alcohol dependence	0.000167	0.00105	CcSEcCtD
Naratriptan—Vomiting—Naltrexone—alcohol dependence	0.000166	0.00104	CcSEcCtD
Naratriptan—Anaphylactic shock—Citalopram—alcohol dependence	0.000165	0.00104	CcSEcCtD
Naratriptan—Oedema—Citalopram—alcohol dependence	0.000165	0.00104	CcSEcCtD
Naratriptan—Rash—Naltrexone—alcohol dependence	0.000165	0.00103	CcSEcCtD
Naratriptan—Dermatitis—Naltrexone—alcohol dependence	0.000165	0.00103	CcSEcCtD
Naratriptan—Infection—Citalopram—alcohol dependence	0.000164	0.00103	CcSEcCtD
Naratriptan—Nausea—Acamprosate—alcohol dependence	0.000164	0.00103	CcSEcCtD
Naratriptan—Headache—Naltrexone—alcohol dependence	0.000164	0.00103	CcSEcCtD
Naratriptan—Shock—Citalopram—alcohol dependence	0.000163	0.00102	CcSEcCtD
Naratriptan—Nervous system disorder—Citalopram—alcohol dependence	0.000162	0.00102	CcSEcCtD
Naratriptan—Thrombocytopenia—Citalopram—alcohol dependence	0.000162	0.00102	CcSEcCtD
Naratriptan—Skin disorder—Citalopram—alcohol dependence	0.000161	0.00101	CcSEcCtD
Naratriptan—Hyperhidrosis—Citalopram—alcohol dependence	0.00016	0.00101	CcSEcCtD
Naratriptan—Nausea—Naltrexone—alcohol dependence	0.000155	0.000975	CcSEcCtD
Naratriptan—Hypotension—Citalopram—alcohol dependence	0.000155	0.000972	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000151	0.000947	CcSEcCtD
Naratriptan—Paraesthesia—Citalopram—alcohol dependence	0.000149	0.000934	CcSEcCtD
Naratriptan—Dyspnoea—Citalopram—alcohol dependence	0.000148	0.000927	CcSEcCtD
Naratriptan—Somnolence—Citalopram—alcohol dependence	0.000147	0.000924	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000143	0.000898	CcSEcCtD
Naratriptan—Fatigue—Citalopram—alcohol dependence	0.000143	0.000896	CcSEcCtD
Naratriptan—Constipation—Citalopram—alcohol dependence	0.000142	0.000889	CcSEcCtD
Naratriptan—Pain—Citalopram—alcohol dependence	0.000142	0.000889	CcSEcCtD
Naratriptan—Feeling abnormal—Citalopram—alcohol dependence	0.000136	0.000857	CcSEcCtD
Naratriptan—Urticaria—Citalopram—alcohol dependence	0.000131	0.000826	CcSEcCtD
Naratriptan—Body temperature increased—Citalopram—alcohol dependence	0.000131	0.000822	CcSEcCtD
Naratriptan—Hypersensitivity—Citalopram—alcohol dependence	0.000122	0.000766	CcSEcCtD
Naratriptan—Asthenia—Citalopram—alcohol dependence	0.000119	0.000746	CcSEcCtD
Naratriptan—Pruritus—Citalopram—alcohol dependence	0.000117	0.000736	CcSEcCtD
Naratriptan—Diarrhoea—Citalopram—alcohol dependence	0.000113	0.000711	CcSEcCtD
Naratriptan—Dizziness—Citalopram—alcohol dependence	0.000109	0.000688	CcSEcCtD
Naratriptan—Vomiting—Citalopram—alcohol dependence	0.000105	0.000661	CcSEcCtD
Naratriptan—Rash—Citalopram—alcohol dependence	0.000104	0.000656	CcSEcCtD
Naratriptan—Dermatitis—Citalopram—alcohol dependence	0.000104	0.000655	CcSEcCtD
Naratriptan—Headache—Citalopram—alcohol dependence	0.000104	0.000651	CcSEcCtD
Naratriptan—Nausea—Citalopram—alcohol dependence	9.83e-05	0.000618	CcSEcCtD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	8.5e-05	0.000687	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—OPRK1—alcohol dependence	8.38e-05	0.000677	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—NPY—alcohol dependence	8.36e-05	0.000676	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CHRM2—alcohol dependence	8.36e-05	0.000675	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ADH6—alcohol dependence	8.35e-05	0.000675	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—OPRM1—alcohol dependence	8.25e-05	0.000667	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	8.22e-05	0.000664	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—HTR2A—alcohol dependence	8.14e-05	0.000658	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—CRH—alcohol dependence	8.07e-05	0.000652	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—HTR1B—alcohol dependence	8.07e-05	0.000652	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	8.05e-05	0.00065	CbGpPWpGaD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	7.98e-05	0.000645	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—DRD4—alcohol dependence	7.98e-05	0.000645	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	7.82e-05	0.000632	CbGpPWpGaD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	7.82e-05	0.000632	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—DRD4—alcohol dependence	7.82e-05	0.000632	CbGpPWpGaD
Naratriptan—MAOA—Biological oxidations—POMC—alcohol dependence	7.74e-05	0.000625	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—OPRM1—alcohol dependence	7.67e-05	0.00062	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—CNR1—alcohol dependence	7.62e-05	0.000616	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—OPRK1—alcohol dependence	7.61e-05	0.000615	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—NPY—alcohol dependence	7.6e-05	0.000614	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—OPRD1—alcohol dependence	7.55e-05	0.00061	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	7.47e-05	0.000603	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—CNR1—alcohol dependence	7.46e-05	0.000603	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—DRD2—alcohol dependence	7.44e-05	0.000601	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—HTR7—alcohol dependence	7.44e-05	0.000601	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—OPRD1—alcohol dependence	7.4e-05	0.000598	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CRH—alcohol dependence	7.33e-05	0.000592	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HTR1B—alcohol dependence	7.33e-05	0.000592	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	7.28e-05	0.000589	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	7.28e-05	0.000589	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—DRD2—alcohol dependence	7.28e-05	0.000588	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—HTR7—alcohol dependence	7.28e-05	0.000588	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PDYN—alcohol dependence	7.24e-05	0.000585	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PDYN—alcohol dependence	7.09e-05	0.000573	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—NPY—alcohol dependence	7.06e-05	0.000571	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—DRD4—alcohol dependence	7.05e-05	0.00057	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ADH1A—alcohol dependence	6.92e-05	0.000559	CbGpPWpGaD
Naratriptan—HTR1D—G alpha (i) signalling events—POMC—alcohol dependence	6.87e-05	0.000555	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—OPRD1—alcohol dependence	6.86e-05	0.000554	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	6.84e-05	0.000553	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HTR1B—alcohol dependence	6.81e-05	0.00055	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CRH—alcohol dependence	6.81e-05	0.00055	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—CNR1—alcohol dependence	6.73e-05	0.000544	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CRHR1—alcohol dependence	6.73e-05	0.000544	CbGpPWpGaD
Naratriptan—HTR1B—G alpha (i) signalling events—POMC—alcohol dependence	6.73e-05	0.000544	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—OPRD1—alcohol dependence	6.72e-05	0.000543	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	6.7e-05	0.000541	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CRHR1—alcohol dependence	6.59e-05	0.000533	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PDYN—alcohol dependence	6.58e-05	0.000531	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—HTR7—alcohol dependence	6.57e-05	0.000531	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—DRD2—alcohol dependence	6.57e-05	0.000531	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—POMC—alcohol dependence	6.5e-05	0.000526	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PDYN—alcohol dependence	6.44e-05	0.00052	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—DRD4—alcohol dependence	6.41e-05	0.000518	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—OPRD1—alcohol dependence	6.34e-05	0.000512	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CHRM2—alcohol dependence	6.33e-05	0.000512	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—AVP—alcohol dependence	6.26e-05	0.000506	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CHRM2—alcohol dependence	6.2e-05	0.000501	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	6.13e-05	0.000495	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—AVP—alcohol dependence	6.13e-05	0.000495	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CNR1—alcohol dependence	6.12e-05	0.000494	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CRHR1—alcohol dependence	6.11e-05	0.000494	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PDYN—alcohol dependence	6.08e-05	0.000491	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—OPRK1—alcohol dependence	6.03e-05	0.000487	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CRHR1—alcohol dependence	5.99e-05	0.000484	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HTR7—alcohol dependence	5.97e-05	0.000482	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—DRD2—alcohol dependence	5.97e-05	0.000482	CbGpPWpGaD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	5.95e-05	0.000481	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—DRD4—alcohol dependence	5.95e-05	0.000481	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—OPRK1—alcohol dependence	5.9e-05	0.000477	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ADH4—alcohol dependence	5.88e-05	0.000475	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—OPRM1—alcohol dependence	5.81e-05	0.00047	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CHRM2—alcohol dependence	5.75e-05	0.000465	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—OPRM1—alcohol dependence	5.69e-05	0.00046	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CNR1—alcohol dependence	5.68e-05	0.000459	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—WASF2—alcohol dependence	5.65e-05	0.000456	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CRHR1—alcohol dependence	5.65e-05	0.000456	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—OPRD1—alcohol dependence	5.63e-05	0.000455	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CHRM2—alcohol dependence	5.63e-05	0.000455	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—EP300—alcohol dependence	5.55e-05	0.000448	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—DRD2—alcohol dependence	5.55e-05	0.000448	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HTR7—alcohol dependence	5.55e-05	0.000448	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—AVP—alcohol dependence	5.53e-05	0.000447	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	5.46e-05	0.000441	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—WASF1—alcohol dependence	5.41e-05	0.000438	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PDYN—alcohol dependence	5.4e-05	0.000437	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—NPY—alcohol dependence	5.35e-05	0.000432	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	5.35e-05	0.000432	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CHRM2—alcohol dependence	5.31e-05	0.000429	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—OPRM1—alcohol dependence	5.28e-05	0.000427	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—NPY—alcohol dependence	5.24e-05	0.000423	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—HTR2A—alcohol dependence	5.21e-05	0.000421	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—OPRM1—alcohol dependence	5.17e-05	0.000418	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR1B—alcohol dependence	5.16e-05	0.000417	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CRH—alcohol dependence	5.16e-05	0.000417	CbGpPWpGaD
Naratriptan—HTR1A—G alpha (i) signalling events—POMC—alcohol dependence	5.12e-05	0.000414	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—OPRD1—alcohol dependence	5.12e-05	0.000414	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	5.1e-05	0.000412	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—HTR2A—alcohol dependence	5.1e-05	0.000412	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CRH—alcohol dependence	5.05e-05	0.000408	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—AVP—alcohol dependence	5.02e-05	0.000406	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CRHR1—alcohol dependence	5.02e-05	0.000406	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ADH7—alcohol dependence	5e-05	0.000404	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PDYN—alcohol dependence	4.91e-05	0.000396	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—OPRM1—alcohol dependence	4.88e-05	0.000394	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—NPY—alcohol dependence	4.86e-05	0.000393	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GGT2—alcohol dependence	4.79e-05	0.000387	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—NPY—alcohol dependence	4.76e-05	0.000384	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CHRM2—alcohol dependence	4.72e-05	0.000382	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—EP300—alcohol dependence	4.72e-05	0.000381	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CRH—alcohol dependence	4.69e-05	0.000379	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR1B—alcohol dependence	4.69e-05	0.000379	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—AVP—alcohol dependence	4.67e-05	0.000377	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—HTR2A—alcohol dependence	4.6e-05	0.000372	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CRH—alcohol dependence	4.59e-05	0.000371	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CRHR1—alcohol dependence	4.56e-05	0.000369	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—DRD4—alcohol dependence	4.51e-05	0.000365	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—OPRK1—alcohol dependence	4.5e-05	0.000363	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NPY—alcohol dependence	4.49e-05	0.000363	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—DRD4—alcohol dependence	4.42e-05	0.000357	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ADH1B—alcohol dependence	4.39e-05	0.000354	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—OPRM1—alcohol dependence	4.34e-05	0.00035	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR1B—alcohol dependence	4.33e-05	0.00035	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CRH—alcohol dependence	4.33e-05	0.00035	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CNR1—alcohol dependence	4.31e-05	0.000348	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CHRM2—alcohol dependence	4.29e-05	0.000347	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CNR1—alcohol dependence	4.22e-05	0.000341	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR7—alcohol dependence	4.2e-05	0.00034	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—DRD2—alcohol dependence	4.2e-05	0.00034	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HTR2A—alcohol dependence	4.18e-05	0.000338	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—POMC—alcohol dependence	4.16e-05	0.000336	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—DRD2—alcohol dependence	4.11e-05	0.000332	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR7—alcohol dependence	4.11e-05	0.000332	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—DRD4—alcohol dependence	4.1e-05	0.000331	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	4.07e-05	0.000329	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—POMC—alcohol dependence	4.07e-05	0.000329	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—OPRD1—alcohol dependence	4.05e-05	0.000327	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—DRD4—alcohol dependence	4.01e-05	0.000324	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—NPY—alcohol dependence	3.99e-05	0.000322	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—OPRD1—alcohol dependence	3.97e-05	0.000321	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—OPRM1—alcohol dependence	3.94e-05	0.000318	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CNR1—alcohol dependence	3.91e-05	0.000316	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PDYN—alcohol dependence	3.89e-05	0.000314	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HTR2A—alcohol dependence	3.88e-05	0.000314	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR1B—alcohol dependence	3.85e-05	0.000311	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CRH—alcohol dependence	3.85e-05	0.000311	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CNR1—alcohol dependence	3.83e-05	0.000309	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—DRD2—alcohol dependence	3.82e-05	0.000308	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR7—alcohol dependence	3.82e-05	0.000308	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PDYN—alcohol dependence	3.8e-05	0.000307	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—DRD4—alcohol dependence	3.78e-05	0.000306	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—DRD2—alcohol dependence	3.74e-05	0.000302	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR7—alcohol dependence	3.74e-05	0.000302	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—POMC—alcohol dependence	3.68e-05	0.000297	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—MAOB—alcohol dependence	3.63e-05	0.000294	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—NPY—alcohol dependence	3.62e-05	0.000293	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CNR1—alcohol dependence	3.61e-05	0.000292	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CRHR1—alcohol dependence	3.61e-05	0.000292	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—WASF2—alcohol dependence	3.61e-05	0.000292	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—AVP—alcohol dependence	3.54e-05	0.000286	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—WASF2—alcohol dependence	3.54e-05	0.000286	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CRHR1—alcohol dependence	3.54e-05	0.000286	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—DRD2—alcohol dependence	3.52e-05	0.000285	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR7—alcohol dependence	3.52e-05	0.000285	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CRH—alcohol dependence	3.5e-05	0.000282	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR1B—alcohol dependence	3.5e-05	0.000282	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—AVP—alcohol dependence	3.46e-05	0.00028	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—WASF1—alcohol dependence	3.46e-05	0.00028	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CHRM2—alcohol dependence	3.4e-05	0.000274	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—WASF1—alcohol dependence	3.39e-05	0.000274	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—DRD4—alcohol dependence	3.36e-05	0.000272	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—POMC—alcohol dependence	3.34e-05	0.00027	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CHRM2—alcohol dependence	3.33e-05	0.000269	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CNR1—alcohol dependence	3.21e-05	0.00026	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—AVP—alcohol dependence	3.21e-05	0.00026	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—AVP—alcohol dependence	3.14e-05	0.000254	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR7—alcohol dependence	3.13e-05	0.000253	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—DRD2—alcohol dependence	3.13e-05	0.000253	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—OPRM1—alcohol dependence	3.12e-05	0.000252	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—POMC—alcohol dependence	3.1e-05	0.000251	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ALDH2—alcohol dependence	3.09e-05	0.00025	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—DRD4—alcohol dependence	3.06e-05	0.000247	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—OPRM1—alcohol dependence	3.05e-05	0.000247	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—OPRD1—alcohol dependence	3.02e-05	0.000244	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—AVP—alcohol dependence	2.97e-05	0.00024	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR2A—alcohol dependence	2.94e-05	0.000238	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CNR1—alcohol dependence	2.92e-05	0.000236	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PDYN—alcohol dependence	2.9e-05	0.000234	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR2A—alcohol dependence	2.88e-05	0.000233	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NPY—alcohol dependence	2.87e-05	0.000232	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—DRD2—alcohol dependence	2.85e-05	0.00023	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR7—alcohol dependence	2.85e-05	0.00023	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NPY—alcohol dependence	2.81e-05	0.000227	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CRH—alcohol dependence	2.77e-05	0.000224	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR1B—alcohol dependence	2.77e-05	0.000224	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CRH—alcohol dependence	2.71e-05	0.000219	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—WASF2—alcohol dependence	2.69e-05	0.000218	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CRHR1—alcohol dependence	2.69e-05	0.000218	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR2A—alcohol dependence	2.67e-05	0.000216	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AVP—alcohol dependence	2.64e-05	0.000213	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GOT2—alcohol dependence	2.63e-05	0.000212	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR2A—alcohol dependence	2.62e-05	0.000211	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—WASF1—alcohol dependence	2.58e-05	0.000209	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CHRM2—alcohol dependence	2.53e-05	0.000205	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CYP2E1—alcohol dependence	2.47e-05	0.0002	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR2A—alcohol dependence	2.47e-05	0.0002	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—DRD4—alcohol dependence	2.42e-05	0.000196	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AVP—alcohol dependence	2.4e-05	0.000194	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—DRD4—alcohol dependence	2.37e-05	0.000191	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—POMC—alcohol dependence	2.35e-05	0.00019	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—OPRM1—alcohol dependence	2.33e-05	0.000188	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CNR1—alcohol dependence	2.31e-05	0.000187	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—POMC—alcohol dependence	2.3e-05	0.000186	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GGT1—alcohol dependence	2.27e-05	0.000183	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GOT1—alcohol dependence	2.27e-05	0.000183	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CNR1—alcohol dependence	2.26e-05	0.000183	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR7—alcohol dependence	2.25e-05	0.000182	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—DRD2—alcohol dependence	2.25e-05	0.000182	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—DRD2—alcohol dependence	2.21e-05	0.000178	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR7—alcohol dependence	2.21e-05	0.000178	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR2A—alcohol dependence	2.2e-05	0.000177	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NPY—alcohol dependence	2.14e-05	0.000173	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—POMC—alcohol dependence	2.13e-05	0.000172	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—POMC—alcohol dependence	2.09e-05	0.000169	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR1B—alcohol dependence	2.06e-05	0.000167	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CRH—alcohol dependence	2.06e-05	0.000167	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR2A—alcohol dependence	1.99e-05	0.000161	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—POMC—alcohol dependence	1.97e-05	0.000159	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AVP—alcohol dependence	1.9e-05	0.000153	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AVP—alcohol dependence	1.86e-05	0.00015	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DRD4—alcohol dependence	1.8e-05	0.000146	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—POMC—alcohol dependence	1.75e-05	0.000142	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CNR1—alcohol dependence	1.72e-05	0.000139	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DRD2—alcohol dependence	1.68e-05	0.000136	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR7—alcohol dependence	1.68e-05	0.000136	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—POMC—alcohol dependence	1.59e-05	0.000129	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR2A—alcohol dependence	1.58e-05	0.000128	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR2A—alcohol dependence	1.55e-05	0.000125	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AVP—alcohol dependence	1.42e-05	0.000114	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—POMC—alcohol dependence	1.32e-05	0.000107	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—EP300—alcohol dependence	1.31e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—POMC—alcohol dependence	1.26e-05	0.000102	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—POMC—alcohol dependence	1.23e-05	9.98e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR2A—alcohol dependence	1.18e-05	9.52e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—POMC—alcohol dependence	9.4e-06	7.6e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—EP300—alcohol dependence	8.78e-06	7.09e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EP300—alcohol dependence	8.36e-06	6.76e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EP300—alcohol dependence	8.19e-06	6.62e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EP300—alcohol dependence	6.24e-06	5.04e-05	CbGpPWpGaD
